Aortic isthmus doppler in early fetal growth restriction
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study looks at blood flow in a specific part of the fetal heart (the aortic isthmus) in babies who are growing slowly in the womb (fetal growth restriction). It aims to see how this blood flow changes and relates to other monitoring measurements, which may help doctors better understand and manage this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with a single baby (not twins or more).
- Your baby has been diagnosed with fetal growth restriction, meaning the estimated fetal weight is below the 10th percentile for the gestational age.
- You are willing to provide written consent to participate in the study.
- Your baby does not have major structural abnormalities, especially heart defects.
- You do not have severe medical conditions like uncontrolled diabetes or lupus.
- Your due date is certain, and your baby is still alive at the time of the Doppler assessment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how blood flow measurements (Doppler) in the baby's ductus venosus (a small blood vessel near the heart) relate to pregnancy outcomes, especially for babies who are smaller than expected. If you join, researchers will track these measurements and your baby's health to see if they can predict better or worse outcomes.
This study uses special imaging techniques to look at the placenta during pregnancy. It aims to learn more about normal pregnancies and those where the baby is growing more slowly than expected.
This study monitors the baby's heart in the womb during late pregnancy to make sure it is developing well. It may help find any concerns early.
This study looks at whether a difference in blood flow measurements between the two babies (called the cerebroplacental ratio) at 16-20 weeks can help predict complications in twin pregnancies where the babies share a placenta. It may help doctors identify which twins need extra monitoring.
This study uses a special ultrasound method (speckle tracking echocardiography) to look for early signs that a twin pregnancy may have impaired fetal growth. It may help clinicians detect problems earlier and better understand how twin babies’ hearts and growth are affected.
This study looks at two ways to manage early-onset fetal growth restriction (when a baby is smaller than expected). It compares using blood tests for angiogenic factors versus feto-placental Doppler ultrasound to guide care. The goal is to find the best way to monitor and protect your baby's health.
Hear when a new Fetal Growth Restriction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.